These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9226747)

  • 1. Free radical scavenging properties of alacepril metabolites and lisinopril.
    Noda Y; Mori A; Packer L
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
    Anning PB; Grocott-Mason RM; Lewis MJ
    Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
    Mira ML; Silva MM; Queirós MJ; Manso C
    Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.
    Suzuki S; Sato H; Shimada H; Takashima N; Arakawa M
    Pharmacology; 1993 Jul; 47(1):61-5. PubMed ID: 8393194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
    Mehta JL; Nicolini FA; Lawson DL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive mechanism of alacepril. Effects of its metabolites on the peripheral sympathetic nervous system.
    Minato H; Hosoki K; Hayashi K; Sawayama T; Kadokawa T; Hashimoto M
    Arzneimittelforschung; 1989 Mar; 39(3):319-24. PubMed ID: 2547387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
    Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
    Mira ML; Silva MM; Queiroz MJ; Manso CF
    Free Radic Res Commun; 1993; 19(3):173-81. PubMed ID: 8244086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radicals produced by bronchoalveolar lavage cells in young and aged guinea pigs.
    Teramoto S; Suzuki M; Matsuse T; Ohga E; Ishii T; Ouchi Y
    Aging (Milano); 2000 Feb; 12(1):22-8. PubMed ID: 10746428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages.
    Suzuki M; Teramoto S; Katayama H; Ohga E; Matsuse T; Ouchi Y
    J Asthma; 1999 Dec; 36(8):665-70. PubMed ID: 10609621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro.
    Nakagawa K; Ueno A; Nishikawa Y
    Yakugaku Zasshi; 2006 Jan; 126(1):37-42. PubMed ID: 16394648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
    Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
    Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study.
    Noda Y; Mori A; Packer L
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):115-24. PubMed ID: 9226746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase activity of the captopril-iron complex.
    Jay D; Cuella A; Jay E
    Mol Cell Biochem; 1995 May; 146(1):45-7. PubMed ID: 7651376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
    Chopra M; Beswick H; Clapperton M; Dargie HJ; Smith WE; McMurray J
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.